metricas
covid
Medicina Clínica Práctica Massive subcutaneous emphysema
Información de la revista
Vol. 5. Núm. 4.
(Octubre - Diciembre 2022)
Vol. 5. Núm. 4.
(Octubre - Diciembre 2022)
Images in medicine
Open Access
Massive subcutaneous emphysema
Enfisema subcutáneo masivo
Visitas
726
Daniela Neto
Autor para correspondencia
danielaslneto@live.com.pt

Corresponding author.
, Sandra Barbosa, Jorge Cotter
Internal Medicine Department, Hospital da Senhora da Oliveira, Guimarães, Portugal
Contenido relacionado
Med Clin Pract. 2025;8:10.1016/j.mcpsp.2025.100499
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Descargar PDF
Estadísticas
Figuras (2)
Texto completo

A 73-year-old woman, with a history of arterial hypertension, type 2 diabetes mellitus and obesity. She went to the Emergency Department for dyspnea, having been hospitalized with the diagnosis of decompensated heart failure with type 2 respiratory failure. During hospitalization, for the etiological study of a pleural effusion, a diagnostic thoracentesis was performed, where an empyema was objectified and a chest drain was placed and underwent fibrinolytic therapy and DNAse, having also completed antibiotic therapy with ceftriaxone and azithromycin. As an intercurrence of the chest tube placement, the patient developed grade V subcutaneous emphysema. Thoracic- abdominal-pelvic computed tomography (CT) scan revealed "exuberant bilateral cervical-thoraco- abdominal subcutaneous emphysema with inferior extension to the left and right iliac fossa reaching the inguinal region and exuberant mediastinal emphysema" (Image A). Two subcutaneous drains were placed in the anterior thoracic region along the 3rd intercostal space with significant improvement and almost complete resolution of emphysema in 2 weeks (Image B).

Copyright © 2022. The Author(s)
Descargar PDF
Opciones de artículo
Herramientas